scispace - formally typeset
Search or ask a question

Showing papers by "Janet B. W. Williams published in 2015"


Journal ArticleDOI
TL;DR: The results make a strong case for using strategies to ensure that baseline scoring is truly independent of the pressure to enroll, and are consistent with the potential for qualification bias at baseline when rated by sites.
Abstract: Lack of standardization across sites and raters, poor interrater reliability, and possible scoring bias affecting the primary outcome measure contribute to a high failure rate in anxiety trials. Remote centralized raters who are blinded to protocol inclusion and exclusion criteria as well as visit number may standardize assessments across raters and eliminate scoring bias, decreasing placebo response and thereby increasing signal detection. The purpose of the primary study was to test the safety and efficacy of an anxiolytic in a double-blind, placebo-controlled (no active comparator), multicenter trial. However, there was an additional prospective objective to explore site ratings compared with remote centralized ratings in the cohort of subjects on placebo. Site raters assessed subjects 6 times over an 8-week period. The primary outcome measure was the week 8 site-rated Hamilton Anxiety Scale (HAM-A). Remote centralized raters by telephone independently rated these subjects on the HAM-A at baseline and week 6. Of the 122 subjects selected by site raters and therefore randomized, remote centralized raters would have admitted 59 (48%) and excluded 63 (52%), based on their HAM-A ratings. The mean change from baseline in HAM-A total score in the placebo group admitted to the study by site raters was 9.3, significantly higher than the 5.9 point mean change on placebo as measured by the remote centralized raters.The data are consistent with the potential for qualification bias at baseline when rated by sites. The results make a strong case for using strategies to ensure that baseline scoring is truly independent of the pressure to enroll.

6 citations


01 Jan 2015
TL;DR: The study design, method of recruitment, and medical and demographic characteristics of the cohort, which will be followed up for 5 years, are described.
Abstract: Although much is known about the virus believed by most experts to be the cause of the acquired immunodeficiency syndrome and about its pathogenic actions, major areas of ignorance remain. Among these are the reasons for the varying time between infection with human immunodeficiency virus and development of acquired immunodeficiency syndrome, the relationship between neurologic and medical aspects of the disease, the time course of neuropsychological findings, and the prevalence of psychiatric morbidity. We assessed 124 homosexual men who were positive for human immunodeficiency virus and 84 who were negative for the virus. In this article we describe the study design, method of recruitment, and medical and demographic characteristics of the cohort, which will be followed up for 5 years.

5 citations


Reference EntryDOI
23 Jan 2015
TL;DR: Robert L. Spitzer led the task force that developed DSM-III, which revolutionized diagnosis and assessment in psychiatry, and his legacy includes several of the most widely used assessment tools, including the Structured Clinical Interview for DSM Disorders and the Patient Health Questionnaire.
Abstract: Robert L. Spitzer (b. 1932) is often described as the most influential psychiatrist of the twentieth century. He led the task force that developed DSM-III, which revolutionized diagnosis and assessment in psychiatry. In addition, Spitzer made major contributions to psychiatric research, and his legacy includes several of the most widely used assessment tools, including the Structured Clinical Interview for DSM Disorders and the Patient Health Questionnaire. Keywords: psychopathology; assessment; classification; depression; diagnosis; schizophrenia